Lumos Diagnostics Secures Baltic Distribution Deal for FebriDx Test
ByAinvest
Wednesday, Dec 17, 2025 11:27 pm ET1min read
Lumos Diagnostics has secured a new European distribution agreement with Interlux Group to roll out its FebriDx point-of-care test across the Baltic region. The agreement enables FebriDx to be distributed into primary care, urgent care, and outpatient settings in Lithuania, Estonia, and Latvia. This expansion comes as Lumos sharpens its commercial focus around FebriDx, particularly in the US and Europe. The company has secured full US Medicare reimbursement for FebriDx and has been working to improve sales efficiency and target high-value healthcare providers in the US.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet